Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Neurosci Res ; 90(5): 955-66, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22302626

RESUMO

Mammalian neurons and all other eukaryotic cells endogenously repair traumatic injury within minutes by a Ca²âº-induced accumulation of vesicles that interact and fuse with each other and the plasmalemma to seal any openings. We have used uptake or exclusion of extracellular fluorescent dye to measure the ability of rat hippocampal B104 cells or rat sciatic nerves to repair (seal) transected neurites in vitro or transected axons ex vivo. We report that endogenous sealing in both preparations is enhanced by Ca²âº-containing solutions and is decreased by Ca²âº-free solutions containing antioxidants such as dithiothreitol (DTT), melatonin (MEL), methylene blue (MB), and various toxins that decrease vesicular interactions. In contrast, the fusogen polyethylene glycol (PEG) at 10-50 mM artificially seals the cut ends of B104 cells and rat sciatic axons within seconds and is not affected by Ca²âº or any of the substances that affect endogenous sealing. At higher concentrations, PEG decreases sealing of transected axons and disrupts the plasmalemma of intact cells. These PEG-sealing data are consistent with the hypothesis that lower concentrations of PEG directly seal a damaged plasmalemma. We have considered these and other data to devise a protocol using a well-specified series of solutions that vary in tonicity, Ca²âº, MB, and PEG content. These protocols rapidly and consistently repair (PEG-fuse) rat sciatic axons in completely cut sciatic nerves in vivo rapidly and dramatically to restore long-lasting morphological continuity, action potential conduction, and behavioral functions.


Assuntos
Axônios/efeitos dos fármacos , Membrana Celular/efeitos dos fármacos , Polietilenoglicóis/uso terapêutico , Neuropatia Ciática/tratamento farmacológico , Cicatrização/efeitos dos fármacos , Animais , Antioxidantes/uso terapêutico , Axotomia , Cálcio/metabolismo , Linhagem Celular Tumoral , Membrana Celular/fisiologia , Modelos Animais de Doenças , Ditiotreitol/uso terapêutico , Relação Dose-Resposta a Droga , Técnicas In Vitro , Melatonina/uso terapêutico , Azul de Metileno , Neuroblastoma/patologia , Polietilenoglicóis/farmacologia , Ratos , Ratos Sprague-Dawley , Neuropatia Ciática/patologia
2.
J Neurosci Res ; 90(5): 945-54, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22497022

RESUMO

To survive, cells must rapidly repair (seal) plasmalemmal damage. Cytosolic oxidation has been shown to increase cell survival in some cases and produce cell death in other protocols. An antioxidant (melatonin; Mel) has been reported to decrease the probability of sealing plasmalemmal damage. Here we report that plasmalemmal damage produces cytosolic oxidation, as assayed by methylene blue (MB) color change in rat B104 hippocampal cells. Plasmalemmal sealing is affected by duration of Ca²âº deprivation and length of exposure to, and concentration of, oxidizing agents such as H2O2 and thimerosal (TH). Cytosolic oxidation by 10 µM to 50 mM H2O2 or 100 µM to 2 mM TH increases the probability of Ca²âº-dependent plasmalemmal sealing, whereas higher concentrations of H2O2 decrease sealing probability and also damage uninjured cells. We also show that antioxidants (Mel, MB) or reducing agents (dithiothreitol) decrease sealing. Proteins, such as protein kinase A, SNAP-25, synaptobrevin, and N-ethylmaleimide-sensitive factor (previously reported to enhance sealing in other pathways), also enhance sealing in this oxidation pathway. In brief, our data show that plasmalemmal damage produces cytosolic oxidation that increases the probability of plasmalemmal sealing, which is strongly correlated with cell survival in other studies. Our results may provide new insights into the etiology and treatment of oxidation-dependent neurodegenerative disorders, such as Parkinson's, Huntington's, and Alzheimer's diseases.


Assuntos
Axotomia , Membrana Celular/fisiologia , Citosol/fisiologia , Neuritos/metabolismo , Cicatrização/fisiologia , Animais , Antioxidantes/farmacologia , Cálcio/metabolismo , Linhagem Celular Tumoral , Membrana Celular/efeitos dos fármacos , Citosol/efeitos dos fármacos , Relação Dose-Resposta a Droga , Interações Medicamentosas , Peróxido de Hidrogênio/farmacologia , Neuritos/efeitos dos fármacos , Neuroblastoma/patologia , Oxidantes/farmacologia , Oxirredução/efeitos dos fármacos , Inibidores de Proteínas Quinases/farmacologia , Ratos , Fatores de Tempo , Cicatrização/efeitos dos fármacos
3.
J Neurosci Res ; 90(5): 967-80, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22302646

RESUMO

Behavioral function lost in mammals (including humans) after peripheral nerve severance is slowly (weeks to years) and often poorly restored by 1-2-mm/day, nonspecifically directed outgrowths from proximal axonal stumps. To survive, proximal stumps must quickly repair (seal) plasmalemmal damage. We report that, after complete cut- or crush-severance of rat sciatic nerves, morphological continuity, action potential conduction, and behavioral functions can be consistently (>98% of trials), rapidly (minutes to days), dramatically (70-85% recovery), and chronically restored and some Wallerian degeneration prevented. We assess axoplasmic and axolemmal continuity by intra-axonal dye diffusion and action potential conduction across the lesion site and amount of behavioral recovery by Sciatic Functional Index and Foot Fault tests. We apply well-specified sequences of solutions containing FDA-approved chemicals. First, severed axonal ends are opened and resealing is prevented by hypotonic Ca²âº-free saline containing antioxidants (especially methylene blue) that inhibit plasmalemmal sealing in sciatic nerves in vivo, ex vivo, and in rat B104 hippocampal cells in vitro. Second, a hypotonic solution of polyethylene glycol (PEG) is applied to open closely apposed (by microsutures, if cut) axonal ends to induce their membranes to flow rapidly into each other (PEG-fusion), consistent with data showing that PEG rapidly seals (PEG-seals) transected neurites of B104 cells, independently of any known endogenous sealing mechanism. Third, Ca²âº-containing isotonic saline is applied to induce sealing of any remaining plasmalemmal holes by Ca²âº-induced accumulation and fusion of vesicles. These and other data suggest that PEG-sealing is neuroprotective, and our PEG-fusion protocols that repair cut- and crush-severed rat nerves might rapidly translate to clinical procedures.


Assuntos
Comportamento Animal/efeitos dos fármacos , Azul de Metileno/uso terapêutico , Microcirurgia/métodos , Polietilenoglicóis/uso terapêutico , Recuperação de Função Fisiológica/fisiologia , Neuropatia Ciática , Análise de Variância , Animais , Modelos Animais de Doenças , Eletromiografia , Potencial Evocado Motor/efeitos dos fármacos , Corantes Fluorescentes , Condução Nervosa/efeitos dos fármacos , Condução Nervosa/fisiologia , Ratos , Ratos Sprague-Dawley , Recuperação de Função Fisiológica/efeitos dos fármacos , Neuropatia Ciática/tratamento farmacológico , Neuropatia Ciática/fisiopatologia , Neuropatia Ciática/cirurgia , Fatores de Tempo , Gravação em Vídeo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA